US Physical Therapy (USPH)
Market Price (12/23/2025): $80.39 | Market Cap: $1.2 BilSector: Health Care | Industry: Health Care Facilities
US Physical Therapy (USPH)
Market Price (12/23/2025): $80.39Market Cap: $1.2 BilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Low stock price volatilityVol 12M is 35% | Weak multi-year price returns2Y Excs Rtn is -51%, 3Y Excs Rtn is -77% | Expensive valuation multiplesP/EPrice/Earnings or Price/(Net Income) is 37x |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more. | Key risksUSPH key risks include [1] significant profitability pressure from government payor rate cuts and [2] challenges in executing its growth strategy, Show more. |
| Low stock price volatilityVol 12M is 35% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -51%, 3Y Excs Rtn is -77% |
| Expensive valuation multiplesP/EPrice/Earnings or Price/(Net Income) is 37x |
| Key risksUSPH key risks include [1] significant profitability pressure from government payor rate cuts and [2] challenges in executing its growth strategy, Show more. |
Why The Stock Moved
Qualitative Assessment
AI Analysis | Feedback
Here are the key points for why US Physical Therapy (USPH) stock moved by approximately -2.3% for the period from August 31, 2025, to December 23, 2025: 1. A notable decline occurred on December 18, 2025, when the stock's closing price of $78.76 represented a 2.08% drop from its opening price of $80.40 on that day.2. This specific daily decline contributed to a broader negative trend observed in the proximate period, as the stock had fallen by 3.64% compared to the previous week, and its market capitalization decreased by 2.11% over the last week leading up to December 23, 2025.
Show more
Stock Movement Drivers
Fundamental Drivers
The 1.4% change in USPH stock from 9/22/2025 to 12/22/2025 was primarily driven by a 4.0% change in the company's Total Revenues ($ Mil).| 9222025 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 79.37 | 80.45 | 1.36% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 729.61 | 758.71 | 3.99% |
| Net Income Margin (%) | 4.57% | 4.36% | -4.73% |
| P/E Multiple | 36.16 | 37.01 | 2.36% |
| Shares Outstanding (Mil) | 15.20 | 15.20 | -0.05% |
| Cumulative Contribution | 1.36% |
Market Drivers
9/22/2025 to 12/22/2025| Return | Correlation | |
|---|---|---|
| USPH | 1.4% | |
| Market (SPY) | 2.7% | 35.0% |
| Sector (XLV) | 13.7% | 28.9% |
Fundamental Drivers
The 7.6% change in USPH stock from 6/23/2025 to 12/22/2025 was primarily driven by a 8.5% change in the company's Total Revenues ($ Mil).| 6232025 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 74.76 | 80.45 | 7.60% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 699.46 | 758.71 | 8.47% |
| Net Income Margin (%) | 4.67% | 4.36% | -6.70% |
| P/E Multiple | 34.65 | 37.01 | 6.83% |
| Shares Outstanding (Mil) | 15.13 | 15.20 | -0.48% |
| Cumulative Contribution | 7.60% |
Market Drivers
6/23/2025 to 12/22/2025| Return | Correlation | |
|---|---|---|
| USPH | 7.6% | |
| Market (SPY) | 14.4% | 32.2% |
| Sector (XLV) | 18.0% | 20.2% |
Fundamental Drivers
The -9.8% change in USPH stock from 12/22/2024 to 12/22/2025 was primarily driven by a -69.4% change in the company's P/E Multiple.| 12222024 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 89.19 | 80.45 | -9.80% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 645.70 | 758.71 | 17.50% |
| Net Income Margin (%) | 1.72% | 4.36% | 153.35% |
| P/E Multiple | 121.13 | 37.01 | -69.44% |
| Shares Outstanding (Mil) | 15.08 | 15.20 | -0.84% |
| Cumulative Contribution | -9.81% |
Market Drivers
12/22/2024 to 12/22/2025| Return | Correlation | |
|---|---|---|
| USPH | -9.8% | |
| Market (SPY) | 16.9% | 44.1% |
| Sector (XLV) | 14.5% | 34.2% |
Fundamental Drivers
The 5.0% change in USPH stock from 12/23/2022 to 12/22/2025 was primarily driven by a 43.0% change in the company's P/E Multiple.| 12232022 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 76.64 | 80.45 | 4.97% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 541.79 | 758.71 | 40.04% |
| Net Income Margin (%) | 7.11% | 4.36% | -38.71% |
| P/E Multiple | 25.88 | 37.01 | 43.03% |
| Shares Outstanding (Mil) | 13.00 | 15.20 | -16.94% |
| Cumulative Contribution | 1.96% |
Market Drivers
12/23/2023 to 12/22/2025| Return | Correlation | |
|---|---|---|
| USPH | -11.3% | |
| Market (SPY) | 47.7% | 44.0% |
| Sector (XLV) | 18.4% | 32.9% |
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| USPH Return | 6% | -19% | -14% | 17% | -3% | -10% | -25% |
| Peers Return | � | � | � | � | � | 3% | � |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 17% | 113% |
Monthly Win Rates [3] | |||||||
| USPH Win Rate | 58% | 42% | 50% | 50% | 42% | 50% | |
| Peers Win Rate | � | � | � | � | 50% | 50% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| USPH Max Drawdown | -58% | -29% | -21% | -1% | -16% | -26% | |
| Peers Max Drawdown | � | � | � | � | � | -19% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: SEM, CON, EHAB, PNTG.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/22/2025 (YTD)
How Low Can It Go
| Event | USPH | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -47.4% | -25.4% |
| % Gain to Breakeven | 90.0% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -64.2% | -33.9% |
| % Gain to Breakeven | 179.3% | 51.3% |
| Time to Breakeven | 314 days | 148 days |
| 2018 Correction | ||
| % Loss | -27.1% | -19.8% |
| % Gain to Breakeven | 37.1% | 24.7% |
| Time to Breakeven | 178 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -64.7% | -56.8% |
| % Gain to Breakeven | 183.6% | 131.3% |
| Time to Breakeven | 657 days | 1,480 days |
Compare to ACHC, AMTU, MCTA, PARK, HCA
In The Past
US Physical Therapy's stock fell -47.4% during the 2022 Inflation Shock from a high on 2/24/2021. A -47.4% loss requires a 90.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
AI Analysis | Feedback
Here are 1-3 brief analogies to describe US Physical Therapy (USPH) succinctly:
The Starbucks of physical therapy clinics.
The Aspen Dental for physical therapy.
The CVS MinuteClinic model for physical therapy.
AI Analysis | Feedback
- Physical Therapy Services: Direct patient care focused on rehabilitation for musculoskeletal, neurological, and post-operative conditions, aiming to restore movement and function.
- Occupational Therapy Services: Direct patient care aimed at helping patients improve their ability to perform daily living and work activities through therapeutic interventions.
- Outpatient Clinic Management Services: Provides administrative, billing, marketing, and operational support to its network of affiliated physical and occupational therapy clinics.
AI Analysis | Feedback
US Physical Therapy (USPH) primarily sells its services directly to individuals.
The up to three categories of customers that it serves are:
- Patients recovering from acute injuries or surgeries: This category includes individuals who have experienced sports injuries, work-related accidents, motor vehicle accidents, or are undergoing post-operative rehabilitation (e.g., after joint replacement, spinal surgery, or other orthopedic procedures).
- Individuals managing chronic conditions or age-related functional decline: This segment comprises patients with chronic pain (such as back pain, neck pain, or fibromyalgia), arthritis, neurological disorders (e.g., stroke, Parkinson's disease, multiple sclerosis), or those experiencing age-related balance issues and decreased mobility.
- Athletes and active individuals seeking performance enhancement or injury prevention: This category includes individuals looking to improve athletic performance, prevent future injuries, enhance flexibility and strength, or safely return to sports and activities after a period of inactivity or minor issue.
AI Analysis | Feedback
nullAI Analysis | Feedback
Christopher J. Reading, Chief Executive Officer and Chairman of the Board of Directors
Mr. Reading has served as Chief Executive Officer and a Director of U.S. Physical Therapy since 2004, and was appointed Chairman of the Board of Directors in May 2024. He previously held the position of President. From 1990 to 2003, Mr. Reading served in various executive and management positions with HealthSouth Corporation, where his last role was Senior Vice President of Operations, responsible for over 200 facilities across 10 states. He started his career as a clinician, graduating with a B.S. in Physical Therapy from the Medical College of Virginia in 1985. Mr. Reading also serves as President of APTQI (Alliance for Physical Therapy, Quality and Innovation).
Carey P. Hendrickson, Chief Financial Officer
Mr. Hendrickson joined U.S. Physical Therapy as Chief Financial Officer in November 2020. Prior to this, he served as Chief Financial Officer at Capital Senior Living Corporation from May 2014 to November 2020. From 2010 through 2014, he was Senior Vice President/Chief Financial Officer and Treasurer of Belo Corp., a television company. He also held various other roles at Belo Corp., including Senior Vice President/Chief Accounting Officer, Vice President/Human Resources, Vice President/Investor Relations and Corporate Communications, and Vice President/Strategic & Financial Planning. Mr. Hendrickson began his career with KPMG LLP and was the director of financial planning for Republic Financial Services before joining Belo in 1992. He holds a BBA in accounting from Baylor University and an MBA from the University of Texas at Arlington.
Eric Williams, President and Chief Operating Officer
Mr. Williams was appointed President and Chief Operating Officer in May 2024. He previously served as Chief Operating Officer for the eastern region of U.S. Physical Therapy from 2021 to 2024. Before joining USPH, he served as President and Chief Operating Officer for Omni Ophthalmic Management Consultants, and prior to that, he was Chief Operating Officer and then Chief Executive Officer of Drayer Physical Therapy Institute, LLC.
Graham Reeve, Chief Operating Officer
Mr. Reeve serves as a Chief Operating Officer for U.S. Physical Therapy.
Rick Binstein, Executive Vice President and General Counsel
Mr. Binstein holds the position of Executive Vice President and General Counsel at U.S. Physical Therapy.
AI Analysis | Feedback
The key risks to US Physical Therapy (USPH) are:
- Reimbursement Pressure from Government Payors: US Physical Therapy faces significant and ongoing pressure from government payors, particularly Medicare, which directly impacts its net revenue per patient visit and overall profitability. Analysts have flagged this as a primary external risk and a constant regulatory headwind. Cumulative rate cuts have reportedly cost USPH millions in annual profits. While the company has implemented strategies to mitigate these cuts, such as boosting commercial and workers' compensation business and driving patient volume, future adjustments to Medicare's payment formula remain a substantial risk.
- Availability and Cost of Qualified Physical Therapists: The business operations of US Physical Therapy are highly dependent on its ability to hire, train, and retain qualified physical therapists. The availability and cost of these professionals represent a continuous operational challenge that can affect staffing levels, service delivery, and overall operating expenses.
- Integration Risk with Acquisitions and Competition in Industrial Injury Prevention: A key component of USPH's growth strategy involves strategic acquisitions. However, these acquisitions carry an inherent risk of integration failure. Furthermore, the company's industrial injury prevention services segment operates in a competitive environment, which could lead to the termination or non-renewal of contractual service arrangements and adverse financial consequences for that business line.
AI Analysis | Feedback
- Rise of Digital Musculoskeletal (MSK) Care Platforms: Companies such as Hinge Health, SWORD Health, and Kaia Health are rapidly expanding, offering virtual and app-based physical therapy programs directly to employers and health plans. These platforms provide a convenient, often lower-cost alternative to traditional in-clinic physical therapy, potentially diverting a significant patient population, particularly for non-acute or chronic conditions, and challenging USPH's core clinic-based business model.
- Acute Shortages and Wage Inflation for Physical Therapists: The physical therapy industry is experiencing escalating shortages of qualified physical therapists and physical therapist assistants. This tight labor market drives up staffing costs and wages, USPH's largest operating expense, and creates significant challenges in recruiting and retaining staff, opening new clinics, and maintaining optimal service capacity. This trend threatens profit margins and limits growth potential.
AI Analysis | Feedback
The addressable market for U.S. Physical Therapy's main products or services in the U.S. is as follows:
- Outpatient Physical and Occupational Therapy Services: The U.S. occupational and physical therapy services market was valued at approximately USD 59.43 billion in 2024. This market is projected to grow to USD 128.17 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2025 to 2032. Another estimate places the U.S. physical therapy services market size at USD 47.59 billion in 2024, with an expected increase to USD 61.70 billion by 2030, growing at a CAGR of 4.60% from 2025 to 2030.
- Industrial Injury Prevention Services: null
AI Analysis | Feedback
US Physical Therapy (USPH) is expected to drive future revenue growth over the next two to three years through a combination of strategic initiatives aimed at expanding its footprint, optimizing reimbursement, growing specialized services, increasing patient volumes, and leveraging technology.
- Clinic Expansion through Acquisitions and De Novo Development: USPH consistently expands its network by acquiring existing practices and opening new "de novo" clinics. In the third quarter of 2025 alone, the company added 18 new clinics, bringing its total to 779, and reported 84 net owned clinic additions since the third quarter of 2024. This ongoing expansion directly contributes to increased patient access and overall revenue.
- Increased Net Rate Per Patient Visit and Payer Rate Initiatives: The company has demonstrated success in enhancing its net rate per patient visit. This is achieved through favorable contract negotiations with commercial and other third-party payors, as well as an increasing proportion of higher-reimbursing workers' compensation cases in its revenue mix. Management also anticipates potential improvements in Medicare pricing in 2026, which would further boost rates. For example, the net rate per patient visit reached $105.54 in Q3 2025.
- Growth in Industrial Injury Prevention (IIP) Services: USPH's Industrial Injury Prevention segment is a significant and consistently growing revenue stream. This segment focuses on providing services to employers for workplace injury prevention and treatment. The IIP net revenues increased by 14.6% year-over-year in Q3 2025, and this growth is often organic. In Q4 2024, IIP revenues saw an impressive 32.1% increase over the prior year.
- Increased Patient Volume and Visits per Clinic: The company has experienced strong patient demand, leading to higher overall patient visits and a record average number of visits per clinic per day. In Q3 2025, total patient visits increased by 18% year-over-year, supported by a 2.2% increase in visits at mature clinics and hitting a record-high average of 32.2 daily patient visits per clinic. This sustained increase in patient traffic across its clinics is a fundamental driver of revenue growth.
- Technology-Driven Efficiency and Enhanced Patient Experience: USPH is investing in technology, such as AI-powered tools for clinical documentation and a "semi-virtualized" front desk model, to streamline operations and reduce administrative burdens. While these initiatives primarily aim to mitigate labor shortages and manage costs, they also enhance patient retention and throughput, allowing clinics to serve more patients efficiently and contribute to incremental revenue, including through new cash-based programs.
AI Analysis | Feedback
Share Repurchases
- The Board of Directors authorized a share repurchase program for up to $25 million through December 31, 2026, as announced during the Q3 2025 earnings call.
Share Issuance
- Operating results per share in 2024 were impacted by an increase in the number of shares outstanding, largely due to a secondary offering completed in May 2023.
- As of November 7, 2025, the number of shares outstanding (issued less treasury stock) was 15,204,119.
Outbound Investments
- Acquisitions remain US Physical Therapy's primary capital allocation priority, consistent with its strategic growth strategy.
- In 2024, the company added 103 clinics and acquired a 75% equity interest in a three-clinic practice with $6.5 million in annual revenues.
- During the first three quarters of 2025, significant acquisitions included a 65% equity interest in a three-clinic practice generating $4.3 million in annual revenue, a 60% equity interest in another three-clinic practice generating $5.3 million in annual revenue, and an outpatient home care physical and speech therapy practice through its 50%-owned subsidiary.
Capital Expenditures
- The company's capital expenditures primarily focus on the expansion of its clinic network through the addition of new clinics and acquisitions.
- USPH added a net of 84 owned clinics since the comparable prior year period, contributing to increased physical therapy operations.
- Specific dollar values for total capital expenditures were not explicitly detailed as a distinct line item within the provided summaries; however, investment in new clinics and acquisitions drives capital deployment.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to USPH. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 21.0% | 21.0% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -8.8% | -8.8% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 11.5% | 11.5% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 2.7% | 2.7% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 13.8% | 13.8% | -5.1% |
| 10312018 | USPH | US Physical Therapy | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 5.6% | 32.8% | -7.3% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for US Physical Therapy
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 19.68 |
| Mkt Cap | 1.2 |
| Rev LTM | 1,048 |
| Op Inc LTM | 75 |
| FCF LTM | 58 |
| FCF 3Y Avg | 59 |
| CFO LTM | 70 |
| CFO 3Y Avg | 66 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 17.5% |
| Rev Chg 3Y Avg | 5.7% |
| Rev Chg Q | 17.0% |
| QoQ Delta Rev Chg LTM | 4.0% |
| Op Mgn LTM | 5.9% |
| Op Mgn 3Y Avg | 4.9% |
| QoQ Delta Op Mgn LTM | 0.2% |
| CFO/Rev LTM | 7.6% |
| CFO/Rev 3Y Avg | 8.0% |
| FCF/Rev LTM | 5.5% |
| FCF/Rev 3Y Avg | 5.3% |
Price Behavior
| Market Price | $80.45 | |
| Market Cap ($ Bil) | 1.2 | |
| First Trading Date | 05/29/1992 | |
| Distance from 52W High | -13.1% | |
| 50 Days | 200 Days | |
| DMA Price | $79.84 | $77.29 |
| DMA Trend | down | down |
| Distance from DMA | 0.8% | 4.1% |
| 3M | 1YR | |
| Volatility | 37.2% | 34.7% |
| Downside Capture | 93.83 | 82.49 |
| Upside Capture | 88.22 | 59.64 |
| Correlation (SPY) | 34.5% | 43.8% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.52 | 1.08 | 1.01 | 1.23 | 0.78 | 0.93 |
| Up Beta | 1.89 | 1.21 | 1.56 | 1.99 | 0.85 | 1.10 |
| Down Beta | 0.80 | 1.29 | 1.32 | 1.89 | 0.78 | 0.80 |
| Up Capture | 27% | 35% | 28% | 53% | 39% | 49% |
| Bmk +ve Days | 13 | 26 | 39 | 74 | 142 | 427 |
| Stock +ve Days | 9 | 22 | 33 | 66 | 116 | 381 |
| Down Capture | 223% | 141% | 110% | 93% | 93% | 100% |
| Bmk -ve Days | 7 | 16 | 24 | 52 | 107 | 323 |
| Stock -ve Days | 11 | 19 | 29 | 59 | 132 | 368 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Comparison of USPH With Other Asset Classes (Last 1Y) | |||||||
|---|---|---|---|---|---|---|---|
| USPH | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -13.3% | 13.6% | 14.7% | 67.3% | 6.8% | -0.5% | -16.6% |
| Annualized Volatility | 34.6% | 17.3% | 19.7% | 19.3% | 15.2% | 17.6% | 35.4% |
| Sharpe Ratio | -0.36 | 0.57 | 0.57 | 2.54 | 0.23 | -0.18 | -0.25 |
| Correlation With Other Assets | 34.3% | 44.4% | 5.1% | 7.4% | 39.2% | 16.5% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Comparison of USPH With Other Asset Classes (Last 5Y) | |||||||
|---|---|---|---|---|---|---|---|
| USPH | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -4.8% | 8.7% | 15.0% | 18.9% | 11.8% | 5.1% | 35.8% |
| Annualized Volatility | 36.6% | 14.5% | 17.1% | 15.5% | 18.7% | 18.9% | 48.9% |
| Sharpe Ratio | -0.04 | 0.42 | 0.71 | 0.98 | 0.51 | 0.18 | 0.63 |
| Correlation With Other Assets | 31.9% | 39.3% | 7.4% | 11.1% | 35.1% | 18.1% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Comparison of USPH With Other Asset Classes (Last 10Y) | |||||||
|---|---|---|---|---|---|---|---|
| USPH | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | 6.5% | 10.0% | 14.9% | 14.9% | 6.7% | 5.5% | 69.9% |
| Annualized Volatility | 39.1% | 16.7% | 18.0% | 14.8% | 17.6% | 20.8% | 55.8% |
| Sharpe Ratio | 0.29 | 0.50 | 0.71 | 0.84 | 0.30 | 0.23 | 0.90 |
| Correlation With Other Assets | 41.1% | 48.4% | 4.4% | 19.4% | 47.7% | 15.8% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/6/2025 | -4.8% | -7.6% | -1.1% |
| 8/7/2025 | 15.2% | 21.8% | 18.4% |
| 5/7/2025 | -0.1% | 8.9% | 9.5% |
| 2/28/2024 | 6.4% | 5.1% | 13.5% |
| 11/8/2023 | -2.7% | 5.7% | 8.8% |
| 8/9/2023 | -9.2% | -12.5% | -20.0% |
| 5/5/2023 | 0.2% | -2.9% | -4.6% |
| 2/23/2023 | 0.8% | 2.7% | -6.9% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 8 | 9 | 11 |
| # Negative | 12 | 11 | 9 |
| Median Positive | 2.3% | 5.1% | 7.1% |
| Median Negative | -3.4% | -8.1% | -20.0% |
| Max Positive | 15.2% | 28.2% | 29.2% |
| Max Negative | -26.9% | -29.4% | -44.5% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11072025 | 10-Q 9/30/2025 |
| 6302025 | 8082025 | 10-Q 6/30/2025 |
| 3312025 | 5092025 | 10-Q 3/31/2025 |
| 12312024 | 3032025 | 10-K 12/31/2024 |
| 9302024 | 11082024 | 10-Q 9/30/2024 |
| 6302024 | 8142024 | 10-Q 6/30/2024 |
| 3312024 | 5082024 | 10-Q 3/31/2024 |
| 12312023 | 2292024 | 10-K 12/31/2023 |
| 9302023 | 11082023 | 10-Q 9/30/2023 |
| 6302023 | 8092023 | 10-Q 6/30/2023 |
| 3312023 | 5052023 | 10-Q 3/31/2023 |
| 12312022 | 2282023 | 10-K 12/31/2022 |
| 9302022 | 11082022 | 10-Q 9/30/2022 |
| 6302022 | 8082022 | 10-Q 6/30/2022 |
| 3312022 | 5092022 | 10-Q 3/31/2022 |
| 12312021 | 3012022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.